Form 8-K - Current report:
SEC Accession No. 0001640334-25-000711
Filing Date
2025-04-28
Accepted
2025-04-28 17:18:39
Documents
27
Period of Report
2025-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 40614
2 ENGAGEMENT AGREEMENT lxrp_ex11.htm EX-1.1 55515
3 AMENDMENT TO ENGAGEMENT AGREEMENT lxrp_ex12.htm EX-1.2 9397
4 PRE-FUNDED WARRANT lxrp_ex41.htm EX-4.1 86918
5 PLACEMENT AGENT WARRANT lxrp_ex42.htm EX-4.2 95519
6 OPINION OF SICHENZIA ROSS lxrp_ex51.htm EX-5.1 14658
7 SECURITIES PURCHASE AGREEMENT lxrp_ex101.htm EX-10.1 196250
8 PRESS RELEASE lxrp_ex991.htm EX-99.1 10442
9 PRESS RELEASE lxrp_ex992.htm EX-99.2 10745
15 lxrp_ex51img2.jpg GRAPHIC 7105
16 lxrp_ex51img1.jpg GRAPHIC 7105
17 lxrp_ex12img1.jpg GRAPHIC 8281
18 lxrp_ex11img2.jpg GRAPHIC 8940
  Complete submission text file 0001640334-25-000711.txt   839001

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20250424.xsd EX-101.SCH 6275
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20250424_lab.xml EX-101.LAB 16212
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20250424_cal.xml EX-101.CAL 898
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20250424_pre.xml EX-101.PRE 11893
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20250424_def.xml EX-101.DEF 4149
29 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5576
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 25881586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)